Rethinking drug design in the artificial intelligence era

Schneider, Petra; Walters, W. Patrick; Sieroka, Norman; Listgarten, Jennifer; Goodnow Jr., Robert A.; Fisher, Jasmin; Jansen, Johanna M.; Duca, José S.; Rush, Thomas S.; Zentgraf, Matthias; Hill, John Edward; Krutoholow, Elizabeth; Kohler, Matthias; Blaney, Jeff; Funatsu, Kimito; Luebkemann, Chris; Schneider, Gisbert

doi:10.1038/s41573-019-0050-3

Metadata only

Date

2020-05

Type

Journal Article

Citations

Cited 200 times in Web of Science

Cited 220 times in Scopus

ETH Bibliography

yes

Altmetrics

Publication status

published

External links

https://doi.org/10.1038/s41573-019-0050-3

Journal / series

Nature Reviews Drug Discovery

Volume

19(5)

Pages / Article No.

353 - 364

Publisher

Nature Publishing Group

Subject

Computational chemistry; Drug development; Drug screening; Drug therapy; Small molecules

Organisational unit

03709 - Kohler, Matthias / Kohler, Matthias
02284 - NFS Digitale Fabrikation / NCCR Digital Fabrication
03852 - Schneider, Gisbert / Schneider, Gisbert

More

Show all metadata

Citations

Cited 200 times in Web of Science

Cited 220 times in Scopus

ETH Bibliography

yes

Altmetrics

Research Collection

Search

Rethinking drug design in the artificial intelligence era Mendeley CSV RIS BibTeX

Rethinking drug design in the artificial intelligence era

Mendeley

CSV

RIS

BibTeX